Table 2 Primer sequences and product sizes for real-time polymerase chain reaction
TargetForward primerReverse primerProduct size (bp)
B2MAGGCTATCCAGCGTACTCCAAAGACGGATGGATGAAACCCAGACACAT105
POLR2AGTGTTCCTTTGAGGAAACGGTGGATCTGCATCAAGCAGGAGGTCAAAG147
RPLPOGGGCACCATTGAAATCCTGAGTGACATTGTCGAACACCTGCTGGATGA140
TBPCCCGAAACGCCGAATATAATCCCATGTTCTTCACTCTTGGCTCCTGTG127
UBCGCAGTTCTTGTTTGTGGATCGCTGTGACATTCTCGATGGTGTCACTGG119
UBE2D2TGGCTCTGAAGAGAATCCACAAGGTCCACCCTGATAGGGACTGTCATT143
DEFA5TCCAGGAAAGAGCTGATGAGGCTAACCTGAGGTTCTAAGAGCAGAGAGTC110
DEFA6AAAGCTTATGAGGCTGATGCCCAGCTTCTGCAATGGCAAGTGAAAGCC134
PLA2G2AGGAAAGGAAGCCGCACTCAGTTATCACATCCACGTTTCTCCAGACGTT139
LYZCCGCTACTGGTGTAATGATGGCAATGCTCTAATGCCTTGTGGATCACG142
VILICATGCGCTGAACTTCATCAAAGCCCCACTTCTGGAAGAGCTGCTGAAA108
IL6CATGTGTGAAAGCAGCAAAGAGGCCACCAGGCAAGTCTCCTCATTGAA112
IL8CTCTTGGCAGCCTTCCTGATTTCTGGGTGGAAAGGTTTGGAGTATGTCT113
  • B2M, β2-microglobulin; POLR2A, polymerase (RNA) II (DNA directed) polypeptide A, 220 kDa; RPLP0, ribosomal protein, large, P0; TBP, TATA box binding protein; UBC, ubiquitin C; UBE2D2, ubiquitin-conjugating enzyme E2D 2; DEFA5, α-defensin 5, Paneth cell-specific; DEFA6, α-defensin 6, Paneth cell-specific; PLA2G2A, phospholipase A2, group IIA (platelets, synovial fluid); LYZ, lysozyme (renal amyloidosis); VIL1, villin 1; IL6, interleukin 6 (interferon-β2); IL8, interleukin 8.